Foyou Pharma(601089.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Foyou Pharma
601089.SH
Beijing Foyou Pharma CO.,LTD engages in the research and development, production, and sale of pharmaceutical preparations and medical devices China and internationally. The company provides chemical drugs and traditional chinese medicines. Its products used in cardiovascular kind, chronic kidney disease, skin disease, digestive system, diabetes, neuropsychiatric system kind, mental nervous system, gynecology, and other therapeutic areas. It also offers disposable oxygen and heart blood tube, sugar urine sick, and other products.
2.805 T
601089.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking29/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE11.50%B
    • Profit Margin12.46%B
    • Gross Margin61.70%A
  • Growth ScoreC
    • Revenue YoY0.34%C
    • Net Profit YoY-10.80%D
    • Total Assets YoY1.35%C
    • Net Assets YoY5.49%C
  • Cash ScoreC
    • Cash Flow Margin78.47%C
    • OCF YoY0.34%C
  • Operating ScoreB
    • Turnover0.71B
  • Debt ScoreA
    • Gearing Ratio21.19%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Foyou Pharma: 6 products are expected to be selected for the 11th batch of national centralized drug procurement

    Zhitong·
    SH
    601089
    -0.67%
    Zhitong·
    SH
    601089
    -0.67%

    Foyou Pharma has obtained the approval notice for the listing application of Clobazam raw materials

    Zhitong·
    SH
    601089
    -0.67%
    Zhitong·
    SH
    601089
    -0.67%

    Foyou Pharma: Dydrogesterone Tablets Obtained Drug Registration Certificate

    Zhitong·
    SH
    601089
    -0.67%
    Zhitong·
    SH
    601089
    -0.67%

    Foyou Pharma: Candesartan Cilexetil and Hydrochlorothiazide Tablets (II) has obtained the drug registration certificate

    Zhitong·
    SH
    601089
    -0.67%
    Zhitong·
    SH
    601089
    -0.67%

    Innovative drug concept stocks continue to decline, BrightGene falls over 8%

    Zhitong·
    SH
    601089
    -0.67%
    SH
    688166
    -2.38%
    SH
    600211
    -1.01%
    Zhitong·
    SH
    601089
    -0.67%
    SH
    688166
    -2.38%
    SH
    600211
    -1.01%
    © 2026 Longbridge｜Disclaimer